Coastal Meds Recalls Pyridoxine Injectable Due to Particulate Matter
Coastal Meds, LLC. is recalling 635 vials of Pyridoxine Injectable due to the presence of unknown particulate matter.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the presence of particulate matter in an injectable drug poses a significant risk of injury, meeting the criteria for a Severe rating.
Plain-English summary
Coastal Meds, LLC. is recalling 635 vials of Pyridoxine Injectable-30 mL. The recall is being conducted because of the presence of unknown particulate matter in the product.
The affected lots are P/121517, CAP/013118, CAP/020518, CAP/021418, and CAP/021918. These products were distributed nationwide in the USA.
Consumers and healthcare providers should stop using the affected vials and contact Coastal Meds, LLC. for further instructions or a refund.
The recalled product
- Product
- PYRIDOXINE Injectable-30 mL MDV Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532
- Manufacturer
- Coastal Meds, LLC.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 635
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lots: P/121517 Discard by 6/13/2018
- CAP/013118 Discard by 4/1/2018
- CAP/020518 Discard by 4/6/2018
- CAP/021418 Discard by 4/15/2018
- CAP/021918 Discard by 4/20/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Coastal Meds, LLC. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Coastal Meds, LLC.
See all →- SevereCoastal Meds Recalls LIPO-DEN PLUS Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- HighFDA Recalls LIPO-DEN Injectable Due to Unknown Particulate Matter
FDA (Drugs) · 2018-05-02
- HighCoastal Meds Recalls Methylcobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereCoastal Meds Recalls Hydroxocobalamin Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
- SevereFDA Recalls Lipoderm Extreme Injectable Due to Particulate Matter
FDA (Drugs) · 2018-05-02
Same hazard · particulate matter
See all →- ModerateIMAAVY Injection Recalled for Presence of Particulate Matter
FDA (Drugs) · 2026-10-14
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls Plum Administration Sets Due to Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
Similar recalls
- CriticalMethotrexate Injection Recalled Due to Presence of Particulate Matter
FDA (Drugs) · 2015-08-19
- SeverePharm D Solutions Recalls Pyridoxine Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereMylan Recalls Cytarabine Injection Vials Due to Particulate Matter
FDA (Drugs) · 2015-08-19
- SevereLidocaine injection recalled due to glass particulate matter
FDA (Drugs) · 2023-11-15
- SevereMylan Recalls Daptomycin Injection Due to Particulate Matter
FDA (Drugs) · 2020-08-12
- HighFDA Recalls AnazaoHealth Injectable Vitamin Solution Due to Particulate Matter
FDA (Drugs) · 2024-01-03